Related references
Note: Only part of the references are listed.Combination of CTLA-4 and PD-1 blockers for treatment of cancer
Anand Rotte
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Advances in cancer immunotherapy 2019-latest trends
Stephan Kruger et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions
Aly-Khan A. Lalani et al.
EUROPEAN UROLOGY (2019)
Emerging Role of Combination Immunotherapy in the First-line Treatment of Advanced Renal Cell Carcinoma A Review
Saby George et al.
JAMA ONCOLOGY (2019)
Cancer immunotherapy beyond immune checkpoint inhibitors
Julian A. Marin-Acevedo et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Inhibitory and Coactivating Receptors Recognising the Same Ligand: Immune Homeostasis Exploited by Pathogens and Tumours
Francesca Levi-Schaffer et al.
TRENDS IN IMMUNOLOGY (2018)
Pathological Bases and Clinical Impact of Intratumor Heterogeneity in Clear Cell Renal Cell Carcinoma
Jose I. Lopez et al.
CURRENT UROLOGY REPORTS (2018)
PD-1 (PDCD1) Promoter Methylation Is a Prognostic Factor in Patients With Diffuse Lower-Grade Gliomas Harboring Isocitrate Dehydrogenase (IDH) Mutations
Lea Kristin Roever et al.
EBIOMEDICINE (2018)
Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG’s receptor ILT2 on peripheral CD8+ T cells
Francois Desgrandchamps et al.
Oncotarget (2018)
Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategies
Cariad Chester et al.
BLOOD (2018)
Potential targeting of B7-H4 for the treatment of cancer
Joseph R. Podojil et al.
IMMUNOLOGICAL REVIEWS (2017)
Novel landscape of HLA-G isoforms expressed in clear cell renal cell carcinoma patients
Diana Tronik-Le Roux et al.
MOLECULAR ONCOLOGY (2017)
Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4
Nathalie Rouas-Freiss et al.
ONCOIMMUNOLOGY (2017)
The immune molecular landscape of the B7 and TNFR immunoregulatory ligand-receptor families in head and neck cancer: A comprehensive overview and the immunotherapeutic implications
Yu-Pei Chen et al.
ONCOIMMUNOLOGY (2017)
Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature
Steven Seaman et al.
CANCER CELL (2017)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours
Holger Moch et al.
EUROPEAN UROLOGY (2016)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality
Ariana Znaor et al.
EUROPEAN UROLOGY (2015)
The consensus molecular subtypes of colorectal cancer
Justin Guinney et al.
NATURE MEDICINE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
HLA-G: An Immune Checkpoint Molecule
Edgardo D. Carosella et al.
ADVANCES IN IMMUNOLOGY, VOL 127 (2015)
VISTA Is an Immune Checkpoint Molecule for Human T Cells
J. Louise Lines et al.
CANCER RESEARCH (2014)
Anti-CD40-mediated cancer immunotherapy: an update of recent and ongoing clinical trials
Sufia Butt Hassan et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2014)
Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy
Xiaozhou Fan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
A comparison of methods for differential expression analysis of RNA-seq data
Charlotte Soneson et al.
BMC BIOINFORMATICS (2013)
PBRM1 and BAP1 as Novel Targets for Renal Cell Carcinoma
James Brugarolas
CANCER JOURNAL (2013)
Emerging Co-signaling Networks in T Cell Immune Regulation
Keunok Jung et al.
Immune Network (2013)
Molecular mechanisms of T cell co-stimulation and co-inhibition
Lieping Chen et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Immunotherapy of Cancer with 4-1BB
Dass S. Vinay et al.
MOLECULAR CANCER THERAPEUTICS (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17
Sophie Agaugue et al.
BLOOD (2011)
Differential expression analysis for sequence count data
Simon Anders et al.
GENOME BIOLOGY (2010)
A comprehensive comparison of random forests and support vector machines for microarray-based cancer classification
Alexander Statnikov et al.
BMC BIOINFORMATICS (2008)
Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting
Alain Dupuy et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
CD70: A new tumor specific biomarker for renal cell carcinoma
K Junker et al.
JOURNAL OF UROLOGY (2005)
Identifying differentially expressed genes using false discovery rate controlling procedures
A Reiner et al.
BIOINFORMATICS (2003)
Gene selection for cancer classification using support vector machines
I Guyon et al.
MACHINE LEARNING (2002)
Comparison of discrimination methods for the classification of tumors using gene expression data
S Dudoit et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2002)
Share Paper
